{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:19:15Z","timestamp":1794201555351,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cachexia is a muscle wasting syndrome occurring in many advanced cancer patients. Cachexia significantly increases cancer morbidity and mortality. Cardiac atrophy and contractility deficits have been observed in patients and in animal models with cancer cachexia, which may contribute to cachexia pathophysiology. However, underlying contributors to decreased in vivo cardiac contractility are not well understood. In this study, we sought to distinguish heart-intrinsic changes from systemic factors contributing to cachexia-associated cardiac dysfunction. We hypothesized that isolated heart and cardiac myocyte functional deficits underlie in vivo contractile dysfunction. To test this hypothesis, isolated heart and cardiac myocyte function was measured in the colon-26 adenocarcinoma murine model of cachexia. Ex vivo perfused hearts from cachectic animals exhibited marked contraction and relaxation deficits during basal and pacing conditions. Isolated myocytes displayed significantly decreased peak contraction and relaxation rates, which was accompanied by decreased peak calcium and decay rates. This study uncovers significant organ and cellular-level functional deficits in cachectic hearts outside of the catabolic in vivo environment, which is explained in part by impaired calcium cycling. These data provide insight into physiological mechanisms of cardiomyopathy in cachexia, which is critical for the ultimate development of effective treatments for patients.<\/jats:p>","DOI":"10.1038\/s41598-021-02688-z","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T11:03:07Z","timestamp":1638961387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cardiac myocyte intrinsic contractility and calcium handling deficits underlie heart organ dysfunction in murine cancer cachexia"],"prefix":"10.1038","volume":"11","author":[{"given":"Michelle L.","family":"Law","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"2688_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jcsm.12402","volume":"10","author":"MS Anker","year":"2019","unstructured":"Anker, M. S. et al. Orphan disease status of cancer cachexia in the USA and in the European Union: A systematic review. J. Cachexia Sarcopenia Muscle 10, 22\u201334 (2019).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2688_CR2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00520-012-1697-z","volume":"21","author":"O Wallengren","year":"2013","unstructured":"Wallengren, O., Lundholm, K. & Bosaeus, I. Diagnostic criteria of cancer cachexia: Relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support. Care Cancer 21, 1569\u20131577 (2013).","journal-title":"Support. Care Cancer"},{"key":"2688_CR3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","volume":"2","author":"MJ Tisdale","year":"2002","unstructured":"Tisdale, M. J. Cachexia in cancer patients. Nat. Rev. Cancer 2, 862\u2013871 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"2688_CR4","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","volume":"90","author":"PJ Ross","year":"2004","unstructured":"Ross, P. J. et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br. J. Cancer 90, 1905\u20131911 (2004).","journal-title":"Br. J. Cancer"},{"key":"2688_CR5","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/13696998.2016.1181640","volume":"19","author":"ST Arthur","year":"2016","unstructured":"Arthur, S. T. et al. Cachexia among US cancer patients. J. Med. Econ. 19, 874\u2013880 (2016).","journal-title":"J. Med. Econ."},{"key":"2688_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0003489414523564","volume":"123","author":"CG Gourin","year":"2014","unstructured":"Gourin, C. G., Couch, M. E. & Johnson, J. T. Effect of weight loss on short-term outcomes and costs of care after head and neck cancer surgery. Ann. Otol., Rhinol. Laryngol. 123, 101\u2013110 (2014).","journal-title":"Ann. Otol., Rhinol. Laryngol."},{"key":"2688_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 12, 489\u2013495 (2011).","journal-title":"Lancet Oncol."},{"key":"2688_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KCH Fearon","year":"2012","unstructured":"Fearon, K. C. H., Glass, D. J. & Guttridge, D. C. Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell Metab. 16, 153\u2013166 (2012).","journal-title":"Cell Metab."},{"key":"2688_CR9","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","volume":"38","author":"EJ Roeland","year":"2020","unstructured":"Roeland, E. J. et al. Management of cancer cachexia: ASCO guideline. J. Clin. Oncol. 38, 2438\u20132453 (2020).","journal-title":"J. Clin. Oncol."},{"key":"2688_CR10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","volume":"35","author":"J Springer","year":"2014","unstructured":"Springer, J. et al. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. Eur. Heart J. 35, 932\u2013941 (2014).","journal-title":"Eur. Heart J."},{"key":"2688_CR11","first-page":"347","volume":"37","author":"M Tian","year":"2010","unstructured":"Tian, M. et al. Cardiac alterations in cancer-induced cachexia in mice. Int. J. Oncol. 37, 347\u2013353 (2010).","journal-title":"Int. J. Oncol."},{"key":"2688_CR12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/jcsm.12451","volume":"10","author":"SMR Kazemi-Bajestani","year":"2019","unstructured":"Kazemi-Bajestani, S. M. R. et al. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung. J. Cachexia Sarcopenia Muscle 10, 1070\u20131082 (2019).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2688_CR13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2014.07.948","volume":"64","author":"L Cramer","year":"2014","unstructured":"Cramer, L. et al. Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer. J. Am. Coll. Cardiol. 64, 1310\u20131319 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2688_CR14","first-page":"1321","volume":"39","author":"M Tian","year":"2011","unstructured":"Tian, M., Asp, M. L., Nishijima, Y. & Belury, M. A. Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice. Int. J. Oncol. 39, 1321\u20131326 (2011).","journal-title":"Int. J. Oncol."},{"key":"2688_CR15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","volume":"71","author":"PF Cosper","year":"2011","unstructured":"Cosper, P. F. & Leinwand, L. A. Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Can. Res. 71, 1710\u20131720 (2011).","journal-title":"Can. Res."},{"key":"2688_CR16","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.18632\/oncotarget.27748","volume":"11","author":"AJ Smuder","year":"2020","unstructured":"Smuder, A. J. et al. Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness. Oncotarget 11, 3502\u20133514 (2020).","journal-title":"Oncotarget"},{"key":"2688_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/rco2.18","volume":"4","author":"DE Lee","year":"2021","unstructured":"Lee, D. E. et al. Cancer-induced cardiac atrophy adversely affects myocardial redox state and mitochondrial oxidative characteristics. JCSM Rapid Commun. 4, 3\u201315 (2021).","journal-title":"JCSM Rapid Commun."},{"key":"2688_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molmet.2015.11.004","volume":"5","author":"M Sch\u00e4fer","year":"2016","unstructured":"Sch\u00e4fer, M. et al. Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia. Mol. Metab. 5, 67\u201378 (2016).","journal-title":"Mol. Metab."},{"key":"2688_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","volume":"15","author":"JM Argil\u00e9s","year":"2018","unstructured":"Argil\u00e9s, J. M., Stemmler, B., L\u00f3pez-Soriano, F. J. & Busquets, S. Inter-tissue communication in cancer cachexia. Nat. Rev. Endocrinol. 15, 9\u201320 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2688_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yjmcc.2015.05.007","volume":"85","author":"SCW Stevens","year":"2015","unstructured":"Stevens, S. C. W. et al. Losartan treatment attenuates tumor-induced myocardial dysfunction. J. Mol. Cell. Cardiol. 85, 37\u201347 (2015).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2688_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","volume":"14","author":"S Von Haehling","year":"2017","unstructured":"Von Haehling, S., Ebner, N., Dos Santos, M. R., Springer, J. & Anker, S. D. Muscle wasting and cachexia in heart failure: Mechanisms and therapies. Nat. Rev. Cardiol. 14, 323\u2013341 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"2688_CR22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-014-0137-y","volume":"5","author":"SMR Kazemi-Bajestani","year":"2014","unstructured":"Kazemi-Bajestani, S. M. R., Becher, H., Fassbender, K., Chu, Q. & Baracos, V. E. Concurrent evolution of cancer cachexia and heart failure: Bilateral effects exist. J. Cachexia Sarcopenia Muscle 5, 95\u2013104 (2014).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2688_CR23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4161\/cbt.12.11.18134","volume":"12","author":"ML Asp","year":"2011","unstructured":"Asp, M. L., Tian, M., Kliewer, K. L. & Belury, M. A. Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia. Cancer Biol. Ther. 12, 957\u2013965 (2011).","journal-title":"Cancer Biol. Ther."},{"key":"2688_CR24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ijc.24784","volume":"126","author":"ML Asp","year":"2010","unstructured":"Asp, M. L., Tian, M., Wendel, A. A. & Belury, M. A. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int. J. Cancer 126, 756\u2013763 (2010).","journal-title":"Int. J. Cancer"},{"key":"2688_CR25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4161\/15384047.2014.987075","volume":"16","author":"KL Kliewer","year":"2015","unstructured":"Kliewer, K. L. et al. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice. Cancer Biol. Ther. 16, 886\u2013897 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"2688_CR26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200420174","volume":"114","author":"S Acharyya","year":"2004","unstructured":"Acharyya, S. et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J. Clin. Investig. 114, 370\u2013378 (2004).","journal-title":"J. Clin. Investig."},{"key":"2688_CR27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2013.12.008","volume":"67","author":"JJ Martindale","year":"2014","unstructured":"Martindale, J. J. & Metzger, J. M. Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization. J. Mol. Cell. Cardiol. 67, 26\u201337 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2688_CR28","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.bpj.2016.03.037","volume":"110","author":"ML Asp","year":"2016","unstructured":"Asp, M. L., Sjaastad, F. V., Siddiqui, J. K., Davis, J. P. & Metzger, J. M. Effects of modified parvalbumin EF-hand motifs on cardiac myocyte contractile function. Biophys. J. 110, 2094\u20132105 (2016).","journal-title":"Biophys. J."},{"key":"2688_CR29","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: The arrive guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).","journal-title":"PLoS Biol."},{"key":"2688_CR30","doi-asserted-by":"crossref","first-page":"e79609","DOI":"10.1371\/journal.pone.0079609","volume":"8","author":"FI Heinis","year":"2013","unstructured":"Heinis, F. I., Andersson, K. B., Christensen, G. & Metzger, J. M. Prominent heart organ-level performance deficits in a genetic model of targeted severe and progressive SERCA2 deficiency. PLoS ONE 8, e79609 (2013).","journal-title":"PLoS ONE"},{"key":"2688_CR31","doi-asserted-by":"crossref","first-page":"R286","DOI":"10.1152\/ajpregu.00517.2012","volume":"304","author":"HL Lujan","year":"2013","unstructured":"Lujan, H. L. & DiCarlo, S. E. Cardiac output, at rest and during exercise, before and during myocardial ischemia, reperfusion, and infarction in conscious mice. Am. J. Physiol.\u2014Regul. Integr. Comp. Physiol. 304, R286\u2013R295 (2013).","journal-title":"Am. J. Physiol.\u2014Regul. Integr. Comp. Physiol."},{"key":"2688_CR32","doi-asserted-by":"crossref","first-page":"e78768","DOI":"10.1371\/journal.pone.0078768","volume":"8","author":"ML Asp","year":"2013","unstructured":"Asp, M. L., Martindale, J. J. & Metzger, J. M. Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling. PLoS ONE 8, e78768 (2013).","journal-title":"PLoS ONE"},{"key":"2688_CR33","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/bioinformatics\/btp184","volume":"25","author":"S Preibisch","year":"2009","unstructured":"Preibisch, S., Saalfeld, S. & Tomancak, P. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 25, 1463\u20131465 (2009).","journal-title":"Bioinformatics"},{"key":"2688_CR34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"2688_CR35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531\u2013543 (2010).","journal-title":"Cell"},{"key":"2688_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C. & Fearon, K. C. H. Cancer-associated cachexia. Nat. Rev. Dis. Primers 4, 1\u201318 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2688_CR37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0022-2828(87)80376-0","volume":"19","author":"C Drott","year":"1987","unstructured":"Drott, C., Waldenstr\u00f6m, A. & Lundholm, K. Cardiac sensitivity and responsiveness to \u03b2-adrenergic stimulation in experimental cancer and undernutrition. J. Mol. Cell. Cardiol. 19, 675\u2013683 (1987).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2688_CR38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0959-8049(99)00273-7","volume":"36","author":"A Hyltander","year":"2000","unstructured":"Hyltander, A., Daneryd, P., Sandstr\u00f6m, R., K\u00f6rner, U. & Lundholm, K. \u03b2-Adrenoceptor activity and resting energy metabolism in weight losing cancer patients. Eur. J. Cancer 36, 330\u2013334 (2000).","journal-title":"Eur. J. Cancer"},{"key":"2688_CR39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autneu.2011.09.006","volume":"166","author":"A Chauhan","year":"2012","unstructured":"Chauhan, A. et al. Exploring autonomic nervous system dysfunction in patients with cancer cachexia: A pilot study. Auton. Neurosci.: Basic Clin. 166, 93\u201395 (2012).","journal-title":"Auton. Neurosci.: Basic Clin."},{"key":"2688_CR40","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1158\/1078-0432.CCR-04-0373","volume":"10","author":"E Lindholm","year":"2004","unstructured":"Lindholm, E. et al. Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients. Clin. Cancer Res. 10, 6855\u20136864 (2004).","journal-title":"Clin. Cancer Res."},{"key":"2688_CR41","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ehf2.12475","volume":"6","author":"MB Heckmann","year":"2019","unstructured":"Heckmann, M. B. et al. Evidence for a cardiac metabolic switch in patients with Hodgkin\u2019s lymphoma. ESC Heart Fail. 6, 824\u2013829 (2019).","journal-title":"ESC Heart Fail."},{"key":"2688_CR42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3945\/ajcn.2010.29885","volume":"92","author":"ZM Wang","year":"2010","unstructured":"Wang, Z. M. et al. Specific metabolic rates of major organs and tissues across adulthood: Evaluation by mechanistic model of resting energy expenditure. Am. J. Clin. Nutr. 92, 1369\u20131377 (2010).","journal-title":"Am. J. Clin. Nutr."},{"key":"2688_CR43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero, E. & Maack, C. Metabolic remodelling in heart failure. Nat. Rev. Cardiol. 15, 457\u2013470 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"2688_CR44","doi-asserted-by":"crossref","first-page":"22001","DOI":"10.18632\/oncotarget.25146","volume":"9","author":"AMY Shum","year":"2018","unstructured":"Shum, A. M. Y. et al. Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: Alterations in sarcomeric and mitochondrial protein expression. Oncotarget 9, 22001\u201322022 (2018).","journal-title":"Oncotarget"},{"key":"2688_CR45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMoa012630","volume":"346","author":"BD Lowes","year":"2002","unstructured":"Lowes, B. D. et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N. Engl. J. Med. 346, 1357\u20131365 (2002).","journal-title":"N. Engl. J. Med."},{"key":"2688_CR46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.RES.86.4.386","volume":"86","author":"S Miyata","year":"2000","unstructured":"Miyata, S., Minobe, W., Bristow, M. R. & Leinwand, L. A. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 86, 386\u2013390 (2000).","journal-title":"Circ. Res."},{"key":"2688_CR47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1096\/fj.09-140566","volume":"24","author":"TJ Herron","year":"2010","unstructured":"Herron, T. J. et al. Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by \u03b1-myosin motor gene transfer. FASEB J. 24, 415\u2013424 (2010).","journal-title":"FASEB J."},{"key":"2688_CR48","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.RES.0000264102.00706.4e","volume":"100","author":"TJ Herron","year":"2007","unstructured":"Herron, T. J. et al. Calcium-independent negative inotropy by \u03b2-myosin heavy chain gene transfer in cardiac myocytes. Circ. Res. 100, 1182\u20131190 (2007).","journal-title":"Circ. Res."},{"key":"2688_CR49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10741-018-9731-y","volume":"24","author":"PM Kostakou","year":"2019","unstructured":"Kostakou, P. M., Kouris, N. T., Kostopoulos, V. S., Damaskos, D. S. & Olympios, C. D. Cardio-oncology: A new and developing sector of research and therapy in the field of cardiology. Heart Fail. Rev. 24, 91\u2013100 (2019).","journal-title":"Heart Fail. Rev."},{"key":"2688_CR50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.lfs.2010.12.010","volume":"88","author":"H Xu","year":"2011","unstructured":"Xu, H. et al. Myocardial dysfunction in an animal model of cancer cachexia. Life Sci. 88, 406\u2013410 (2011).","journal-title":"Life Sci."},{"key":"2688_CR51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yjmcc.2016.09.010","volume":"100","author":"RD Devine","year":"2016","unstructured":"Devine, R. D., Eichenseer, C. M. & Wold, L. E. Minocycline attenuates cardiac dysfunction in tumor-burdened mice. J. Mol. Cell. Cardiol. 100, 35\u201342 (2016).","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02688-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T18:17:56Z","timestamp":1670091476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02688-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2688"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-02688-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23627"}}